MAPK1 and depressive symptom measurement: It remains unclear how the miRNAs extracted in this study increase or decrease MAPK1; however, if they act in a pro-inflammatory manner against MAPK1, this would be consistent with the results of previous studies linking the involvement in inflammation and neuroplasticity to treatment outcomes in depression [13,18].